Keyword: The Medicines Company
Scynexis has nabbed Nkechi Azie as its VP of clinical development from her role as infectious disease head at The Medicines Company.
The Medicines Company announced long-term data for inclisiran, showing that the drug lowered “bad” LDL cholesterol by more than 50%.
Qpex Biopharma launched as a new infectious disease company, simultaneously obtaining $33 million and preclinical assets from The Medicines Company.
PPD unveiled an enrollment model that identifies eligible patients and connects them with study sites before startup, inverting the typical process.
Gilead’s director of oncology clinical research jumps to Compugen, longtime Teva exec becomes Dr. Reddy's COO, Astellas names new ethics & compliance head.
Germano takes up the position 8 months after a shift in focus at Intrexon led him to give up the president post at the synthetic biology company.
Get Tuesday's shot of biopharma news of note.
Silence Therapeutics has asked the U.K. High Court of Justice to rule on an intellectual property dispute with Alnylam and The Medicines Company.
The Medicines Company and RNA biotech partner Alnylam have set out a new, large late-stage test for their next-gen anticholesterol candidate inclisiran, which it hopes will get over the line for approval.
Arriving later to the PCSK9 inhibitor market could actually be beneficial to Alnylam and The Medicines Company, say analysts.